Dynamics of CD81 expression on lymphocyte subsets during interferon-α-based antiviral treatment of patients with chronic hepatitis C

Journal of Leukocyte Biology

Volumn 80, Issue 2, 2006, Pages 298-308

  Kronenberger, Bernd ^a   Herrmann, Eva ^a   Hofmann, W Peter ^a   Wedemeyer, Heiner ^b   Sester, Martina ^a   Mihm, Ulrike ^a   Ghaliai, Temam ^a   Zeuzem, Stefan ^a   Sarrazin, Christoph ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Antiviral immune response; Host cell interaction

Indexed keywords

ALPHA INTERFERON; CD19 ANTIGEN; CD56 ANTIGEN; CD81 ANTIGEN; RIBAVIRIN; VIRUS RNA; ANTIVIRUS AGENT; LEUKOCYTE ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION; B LYMPHOCYTE; CASE CONTROL STUDY; CELL CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METABOLISM; MIDDLE AGED;

HEPATITIS C VIRUS;

ADULT; ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD56; ANTIVIRAL AGENTS; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HEPATITIS, CHRONIC; HUMANS; INTERFERON-ALPHA; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED;

EID: 33748861467     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0106047     Document Type: Article

References (34)

1. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H. G., Mizokami, M., Bartenschlager, R., Liang, T. J. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791-796.
2. Perelson, A. S., Herrmann, E., Micol, F., Zeuzem, S. (2005) New kinetic models for the hepatitis C virus. Hepatology 42, 749-754.
3. Zeuzem, S., Schmidt, J. M., Lee, J. H., Ruster, B., Roth, W. K. (1996) Effect of interferon α on the dynamics of hepatitis C virus turnover in vivo. Hepatology 23, 366-371.
4. Zeuzem, S., Schmidt, J. M., Lee, J. H., von Wagner, M., Teuber, G., Roth, W. K. (1998) Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon α on viral turnover. Hepatology 28, 245-252.
5. Poynard, T., Mathurin, P., Lai, C. L., Guyader, D., Poupon, R., Tainturier, M. H., Myers, R. P., Muntenau, M., Ratziu, V., Manns, M., Vogel, A., Capron, F., Chedid, A., Bedossa, P. (2003) A comparison of fibrosis progression in chronic liver diseases. J. Hepatol. 38, 257-265.
6. Nelson, D. R., Marousis, C. G., Davis, G. L., Rice, C. M., Wong, J., Houghton, M., Lau, J. Y. (1997) The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J. Immunol. 158, 1473-1481.
7. Wedemeyer, H., He, X. S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J., Alter, H., Rehermann, B. (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169, 3447-3458.
8. Gruener, N. H., Lechner, F., Jung, M. C., Diepolder, H., Gerlach, T., Lauer, G., Walker, B., Sullivan, J., Phillips, R., Pape, G. R., Klenerman, P. (2001) Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 75, 5550-5558.
9. Ducoulombier, D., Roque-Afonso, A. M., Di Liberto, G., Penin, F., Kara, R., Richard, Y., Dussaix, E., Feray, C. (2004) Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 39, 817-825.
10. Roque-Afonso, A. M., Ducoulombier, D., Di Liberto, G., Kara, R., Gigou, M., Dussaix, E., Samuel, D., Feray, C. (2005) Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J. Virol. 79, 6349-6357.
11. Lerat, H., Rumin, S., Habersetzer, F., Berby, F., Trabaud, M. A., Trepo, C., Inchauspe, G. (1998) In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 91, 3841-3849.
12. Crotta, S., Stilla, A., Wack, A., D'Andrea, A., Nuti, S., D'Oro, U., Mosca, M., Filliponi, F., Brunetto, R. M., Bonino, F., Abrignani, S., Valiante, N. M. (2002) Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195, 35-41.
13. Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., Abrignani, S. (1998) Binding of hepatitis C virus to CD81. Science 282, 938-941.
14. Soldaini, E., Wack, A., D'Oro, U., Nuti, S., Ulivieri, C., Baldari, C. T., Abrignani, S. (2003) T cell costimulation by the hepatitis C virus envelope protein E2 binding to CD81 is mediated by Lck. Eur. J. Immunol. 33, 455-464.
15. Wack, A., Soldaini, E., Tseng, C., Nuti, S., Klimpel, G., Abrignani, S. (2001) Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur. J. Immunol. 31, 166-175.
16. Zuckerman, E. (2003) Expansion of CD5+ B-cell overexpressing CD81 in HCV infection: towards better understanding the link between HCV infection, B-cell activation and lymphoproliferation. J. Hepatol. 38, 674-676.
17. Zuckerman, E., Slobodin, G., Kessel, A., Sabo, E., Yeshurun, D., Halas, K., Toubi, E. (2002) Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin. Exp. Immunol. 128, 353-358.
18. Cormier, E. G., Tsamis, F., Kajumo, F., Durso, R. J., Gardner, J. P., Dragic, T. (2004) CD81 is an entry coreceptor for hepatitis C virus. Proc. Natl. Acad. Sci. USA 101, 7270-7274.
19. Bartosch, B., Dubuisson, J., Cosset, F. L. (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197, 633-642.
20. McKeating, J. A., Zhang, L. Q., Logvinoff, C., Flint, M., Zhang, J., Yu, J., Butera, D., Ho, D. D., Dustin, L. B., Rice, C. M., Balfe, P. (2004) Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J. Virol. 78, 8496-8505.
21. Zhang, J., Randall, G., Higginbottom, A., Monk, P., Rice, C. M., McKeating, J. A. (2004) CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 78, 1448-1455.
22. Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C. M., McKeating, J. A. (2003) Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl. Acad. Sci. USA 100, 7271-7276.
23. Kronenberger, B., Ruster, B., Elez, R., Weber, S., Piiper, A., Lee, J. H., Roth, W. K., Zeuzem, S. (2001) Interferon α down-regulates CD81 in patients with chronic hepatitis C. Hepatology 33, 1518-1526.
24. Hofmann, W. P., Herrmann, E., Kronenberger, B., Merkwirth, C., Welsch, C., Lengauer, T., Zeuzem, S., Sarrazin, C. (2004) Association of HCV-related mixed cryoglobulinemia with specific mutational pattern of the HCV E2 protein and CD81 expression on peripheral B lymphocytes. Blood 104, 1228-1229.
25. Zuckerman, E., Kessel, A., Slobodin, G., Sabo, E., Yeshurun, D., Toubi, E. (2003) Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection. J. Virol. 77, 10432-10436.
26. Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., Wollman, J. (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1, 431-435.
27. Herrmann, E., Lee, J. H., Marinos, G., Modi, M., Zeuzem, S. (2003) Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon. Hepatology 37, 1351-1358.
28. Lindenbach, B. D., Evans, M. J., Syder, A. J., Wolk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., Rice, C. M. (2005) Complete replication of hepatitis C virus in cell culture. Science 309, 623-626.
29. Ducoulombier, D., Roque-Afonso, A. M., Di Liberto, G., Penin, F., Kara, R., Richard, Y., Dussaix, E., Feray, C. (2004) Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 39, 817-825.
30. Fritzsching, B., Schwer, B., Kartenbeck, J., Pedal, A., Horejsi, V., Ott, M. (2002) Release and intercellular transfer of cell surface CD81 via microparticles. J. Immunol. 169, 5531-5537.
31. Levy, S., Todd, S. C., Maecker, H. T. (1998) CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16, 89-109.
32. Witherden, D. A., Boismenu, R., Havran, W. L. (2000) CD81 and CD28 costimulate T cells through distinct pathways. J. Immunol. 165, 1902-1909.
33. Tseng, C. T., Klimpel, G. R. (2002) Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195, 43-49.
34. Rosa, D., Saletti, G., De Gregorio, E., Zorat, F., Comar, C., D'Oro, U., Nuti, S., Houghton, M., Barnaba, V., Pozzato, G., Abrignani, S. (2005) Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc. Natl. Acad. Sci. USA 102, 18544-18549.